NewAmsterdam Pharma Hits Day High with 12.46% Surge in Stock Price

NewAmsterdam Pharma Co. NV has experienced a significant surge in its stock price, gaining 12.46% on May 7, 2026. The stock reached an intraday high of USD 35.16, marking a notable achievement for the small-cap pharmaceutical and biotechnology company. In terms of performance metrics, NewAmsterdam Pharma has outperformed the S&P 500 index over various time frames. Over the past week, the stock has risen by 22.02%, while the S&P 500 saw a modest increase of 1.78%. The one-year performance stands at an impressive 84.2%, compared to the S&P 500's 30.29%. However, year-to-date, NewAmsterdam Pharma has seen a slight decline of 0.66%, contrasting with the S&P 500's gain of 7.18%. Despite these positive short-term trends, the company faces challenges, including a significant drop in net sales and rising raw material costs. Additionally, promoter confidence appears to be waning, with a 2.61% reduction in their stake over the previous quarter. As NewAmsterdam Pharma navigates these dynamics, its recent stock performance highlights the volatility and complexity of the current market landscape.